Roche acquires PathAI: pharma partners face a vendor-risk problem
Roche’s $1.05bn acquisition of PathAI raises new questions around AI infrastructure neutrality, companion diagnostics and vendor governance
Topic Archive
The latest Galen Growth articles, analysis, and market perspectives about Digital Pathology in digital health.
Browse
